The team independently developed the first new triazine anti-coccidiosis veterinary drug with completely new chemical structure, Ethanamizuril, in China. This drug has outstanding characteristics such as high safety, wide anti-coccidiosis spectrum and excellent efect. It improves the prevention and treatment of coccidiosis. At the same time, the research results have broken through the key technologies such as drug production process, quality standard and residue standard formulation by the innovation of synthetic process and preparation process. The dosage form and administration mode of Ethanamizuril are more suitable for the poultry breeding mode in China, and help to delay the development of coccidia resistance. It has obtained 2 national Class-I new veterinary drug certificates, and thereby becoming the first innovative veterinary drug that can be used for food animals in the field of chemical drugs in China in the past 17 years, which has improved the situation of drug resistance and no drug availability in coccidia control in China. The research achievements of Ethanamizuril have also applied for and obtained 3 Chinese national invention patents and 2 international invention patents (PCT).

New veterinary drug certificates